Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2836
www.abbvie.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc.
November 2025's Select Stocks That May Be Priced Below Estimated Value
- Nov 11th, 2025 10:38 am
IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock Soars
- Nov 11th, 2025 7:56 am
3 Value Stock Picks Including Laureate Education For Estimated Undervaluation
- Nov 11th, 2025 4:38 am
How Analyst Views Are Shaping the Evolving Story for AbbVie
- Nov 10th, 2025 9:05 am
Is AbbVie's (ABBV) Dividend Hike Amid Margin Pressures Shaping Its Investment Appeal?
- Nov 10th, 2025 8:12 am
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs?
- Nov 10th, 2025 5:47 am
QurAlis Announces Appointment of Manoj Malhotra, M.D., as Chief Medical Officer
- Nov 10th, 2025 5:45 am
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.
- Nov 9th, 2025 9:05 am
Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now
- Nov 9th, 2025 2:21 am
Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating
- Nov 7th, 2025 10:36 pm
November 2025's Top Stocks Priced Below Estimated Value
- Nov 7th, 2025 10:38 am
The Top 5 Analyst Questions From AbbVie’s Q3 Earnings Call
- Nov 6th, 2025 10:32 pm
Record Earnings for Gubra; Revised Outlook for the CRO Business
- Nov 6th, 2025 9:30 am
Chronic Heart Failure Market Analysis and Forecast, 2025-2035, Featuring AstraZeneca, Bristol Myers Squibb, Cytokinetics, Bayer, Eli Lilly and Other Leading Players
- Nov 6th, 2025 8:23 am
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November
- Nov 6th, 2025 6:45 am
Former blockbuster Linzess grows label with paediatric IBS-C approval
- Nov 6th, 2025 5:35 am
REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights
- Nov 6th, 2025 5:05 am
Lower interest rates could boost these stocks & sectors
- Nov 6th, 2025 4:30 am
Jim Cramer Says “I Found the AbbVie Call Particularly Jarring”
- Nov 5th, 2025 9:11 pm
AbbVie Just Raised Its Dividend by 5.5%. Should You Buy ABBV Stock Here?
- Nov 5th, 2025 5:30 pm
Scroll